RecruitingNCT04442789

Sequelae of Sars-CoV-2 Infections

Long-term Sequelae of Severe Sars-CoV-2 Infections


Sponsor

University of Giessen

Enrollment

120 participants

Start Date

May 20, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy. To date, no vaccine or therapy is available. Severe courses of the infection not only affect the lungs, but also other organs like the heart, kidney, or liver. The lack of preexisting immunity might at least partially explain the affection of extra pulmonary organs not yet seen in infections due to other respiratory viruses. In this observational investigation the study group will follow up on patients that have been hospitalized due to a SARS-CoV-2 infection, and monitor sequelae in various organs, with an emphasis on the pulmo-cardiovascular system. Our that in some patients, organ damage will persist and require long-term medical care.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • hospitalization due to Sars-CoV-2 infection

Exclusion Criteria1

  • under 18 years of age

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University

Giessen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04442789


Related Trials